SOX4 and hyperlipidemia: Additionally, we observed a predicted increase in Sox4 activity (Fig. 2i), which has been described as being upregulated in response to hyperlipidemia and hyperglycemia, promoting endothelial to mesenchymal transition, inflammation, and angiogenesis in pathological settings25,26.